Fact CheckerSign in

NCT02108028Completed

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

An Exploratory Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer and Other Chronic Illnesses

Source: ClinicalTrials.gov · Last updated 26 Oct 2026

Brief summary (registry, in English)

Background: \- There are very few documents to help young adults living with advanced cancer discuss their concerns and end-of-life preferences. A new document, Voicing My CHOiCES, allows young adults to explain what kind of care they would want if they became unable to communicate or make medical decisions on their own. Researchers want to study if this document is helpful. Objective: \- To study if Voicing My CHOiCES(TM) can reduce anxiety, improve sense of support, and improve communication about advanced care planning. Eligibility: \- Adults 18 to 39 years old being treated for cancer. Design: * Participants will answer questions about their age, sex, employment, religion, health, and marital status. They will also complete several brief questionnaires: 1. General Anxiety Short Form 2. Peace, Equanimity and Acceptance in the Cancer Experience 3. Functional Assessment of Social Support 4. Quality of Communication 5. Prior Communication about Advanced Care Planning * Then a health care professional will introduce Voicing My CHOiCES . Participants will review the document and comment on parts they find relevant. They will also say if any important items are missing. Participants will complete 3 pages of the document with the assistance of a health care provider. They will be asked for positive and negative observations. * The second stage of the study will take place about 1 month later. Participants will repeat the brief questionnaires listed above. They will be asked if they shared any of the preferences they described when completing the 3 pages of Voicing My CHOiCES during visit 1 with a family member, friend, or health care provider. Research staff will ask the participant for permission to contact the people they spoke with in order to learn whether their conversations about the document were helpful. They will ask for feedback on how to make Voicing My CHOiCES more helpful.

Status (registry)
Completed
Study type
Observational
Enrollment
272 (actual)
First submitted
5 Apr 2014
Start date
3 Apr 2014
Primary completion date
16 Aug 2023
Lead sponsor
National Cancer Institute (NCI)
Diseases
HIV
NCT number
NCT02108028

What you commit to

  • Study type: Observational
  • Participants enrolled: 272
  • From 3 Apr 2014 to the primary completion date, 16 Aug 2023
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment which in the judgment of the Principal or Associate Investigatorwould compromise the patient s ability to understand the VMC material or is likely to interfere with the study procedures or results.
  • Clinically significant, systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction) which in the judgment of the research team would compromise the patient s ability to tolerate or complete this study.

Other

  • Presence of psychotic symptoms or severe psychological distress, which in the judgment of the Principal or Associate Investigator or consulting psychiatrist would compromise the patient s ability to engage in the intervention or is likely to interfere with the study procedures or results.
  • Participants who have already completed the Voicing My CHOiCES tool.
    • ELIGIBILITY CRITERIA FOR NON-PATIENT PARTICPANTS (COHORT 4):

Who the study is looking for

  • Patients must be between ages: 18 through 39 years
  • Patients must be diagnosed with cancer or other chronic illness.
  • Patients must give informed consent.
  • Patients must have a score of 3 or less on the Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS; Appendix
  • Patients must be English or Spanish speaking.
    • Cohorts 1B and 2B must be English speaking only.
  • Subject must be greater than or equal to 18 years of age
  • Family/friend and/or health care providers must be English or Spanish speaking.
  • Family/friend and health care providers must provide informed consent.

Criteria the registry did not label

  • ELIGIBILITY CRITERIA FOR PATIENT PARTICIPANTS (COHORT 1A, 1B, 2A, 2B, 3A \& 3B):

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Johns Hopkins Hospital
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status
National Institutes of Health Clinical Center
Coordinator of this site? Confirm its status
BethesdaUnited StatesUnknown status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Cook Childrens Hospital
Coordinator of this site? Confirm its status
Fort WorthUnited StatesUnknown status
Children's Hospital of Orange County
Coordinator of this site? Confirm its status
OrangeUnited StatesUnknown status
Rhode Island Hospital, Lifespan
Coordinator of this site? Confirm its status
ProvidenceUnited StatesUnknown status
Moffitt Cancer Center
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status
Children's Hospital at Montefiore
Coordinator of this site? Confirm its status
The BronxUnited StatesUnknown status
Childrens National Medical Center
Coordinator of this site? Confirm its status
Washington D.C.United StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.